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SOME COMMONLY UNRECOGNIZED 
MANIFESTATIONS OF 
METABOLIC ARTHROPATHIES 
MARK J. COBBY, MD AND WILLIAM MARTEL, MD 
The metabolic arthropathies are characterized by 
the deposition of abnormal substances in or around 
joints. Certain features of some of these arthro- 
pathies and their significance have only recently 
been recognized and others have been insufficiently 
emphasized. An important group of conditions are 
the arthropathies related to renal failure and its 
treatment, namely, aluminum toxicity, periarticular 
calcification and crystal deposition, hyperparathy- 
roidism, and dialysis-related amyloidosis. Crystal 
deposition diseases, specifically, gouty arthritis, cal- 
cium pyrophosphate deposition, and calcium hy- 
droxyapatite deposition, are also reviewed. 
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INTRODUCTION 
The metabolic arthropathies are a heterogeneous 
group of disorders many of which result from depo- 
sition of abnormal substances in or around articular 
structures. This article reviews various manifesta- 
tions of several metabolic arthropathies that are of 
current interest, or that have previously been insuffi- 
ciently emphasized. 
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ARTHROPATHIES RELATED TO RENAL 
FAILURE AND ITS TREATMENT 
In the last decade a new complication of long-term 
maintenance hemodialysis has emerged, termed di- 
alysis-related arthropathy. The full extent of this se- 
vere and disabling joint disease is only just begin- 
ning to be realized. As yet it is uncertain whether 
this is a single entity with a spectrum of manifesta- 
tions or an assortment of disorders. It is increasingly 
apparent however, that many of the manifestations 
are secondary to the intraosseous, articular, and pe- 
riarticular accumulation of a previously unrecog- 
nized form of amyloid derived from circulating beta 
2-microglobulin. This will be considered further, fol- 
lowing a discussion of the more frequently recog- 
nized complications of chronic renal failure and its 
treatment. 
Renal osteodystrophy encompasses a spectrum of 
pathological and radiological features resulting from 
a combination of secondary hyperparathyroidism, 
defective mineralization, and decreased bone forma- 
tion. Its pathogenesis is complex, but includes exces- 
sive phosphate retention, resistance to the effect of 
parathyroid hormone, decreased synthesis of l-25 
vitamin D by the kidney and aluminum overload (1). 
The variable radiographic findings of osteomalacia, 
osteoporosis and osteosclerosis, are usually accom- 
panied by soft tissue and vascular calcification (2,~). 
Correcting the metabolic abnormalities and deficien- 
cies has resulted in a decrease in the incidence and 
severity of renal osteodystrophy, but this in turn has 
produced a number of unanticipated complications. 
Aluminum Toxicity 
Aluminum toxicity may result from the use of phos- 
phate binding gels containing aluminum salts to 
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lower the hyperphosphatemia or from dialysis solu- 
tions with a high aluminum content (4, 5). Two sig- 
nificant manifestations of this toxicity include acute 
myoclonic encephalopathy, characterized by epi- 
sodes of abnormal speech, myoclonic jerks and con- 
vulsions (dialysis dementia), and vitamin D-resistant 
osteomalacia, associated with muscle weakness, a 
disproportionately severe anemia and normal serum 
alkaline phosphatase (fracturing dialysis osteodys- 
trophy (6, 7, 8). 
Aluminum is toxic to osteoblasts and binds to os- 
teoid, displacing calcium and inhibiting bone miner- 
alization (9). The radiblogical features of this osteo- 
dystrophy include osteopenia and multiple fractures 
with wide radiolucent osteoid seams that heal 
poorly. These commonly involve the ribs (typically 
the second, third and fourth), vertebrae, hips, and 
pelvis (10, 11). 
Aluminum also accumulates, and is concentrated 
in, articular structures, with the highest concentra- 
tions seen in the presence of amyloid deposition 
(12). As yet, it is uncertain whether it contributes to 
the onset of dialysis-associated arthropathy (x3), but 
a synergistic action between aluminum and amyloid 
has been suggested (14). 
The incidences of dialysis dementia and fractur- 
ing dialysis osteodystrophy have decreased signifi- 
cantly since the lowering of aluminum concentra- 
tions in dialysis solutions and the monitoring of 
plasma aluminum levels, although even modest alu- 
minum overload can cause alterations of cerebral 
function (15). 
Periarticular Calcifications and 
Crystal Deposition 
Soft-tissue calcification occurs in renal failure when 
the plasma concentrations of calcium and phos- 
phorus exceed their solubility product (16). In con- 
trast, vascular calcification is unrelated to the cal- 
cium-phosphorus product, depending instead on the 
duration of dialysis (I 7), Periarticular deposits con- 
sist of hydroxyapatite crystals. They are frequently 
asymptomatic but can result in an aseptic tendonitis 
or periarthritis. The deposits may reach a consider- 
able size, producing tumoral densities, often sym- 
metrically distributed, about the large joints. These 
periarticular deposits may regress or progress during 
dialysis (16, 18). Capsular opacification can also oc- 
cur and bone erosions beneath the periarticular de- 
posits may be seen (19). 
Intraarticular deposition of hydroxyapatite crys- 
tals has been described in the hand in patients who 
also have erosions of metacarpophalangeal and in- 
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terphalangeal joints (20). In the spine, apatite crys- 
tals have been associated with a destructive spondy- 
loarthropathy in long-term dialysis patients (21), but 
a causal relationship between the presence of the 
crystals and the spondyloarthropathy is equivocal. 
In subsequent series amyloid deposition has been 
implicated as the cause of the latter (22, 23). 
Although chronic renal insufficiency results in 
hyperuricemia, tophaceous destructive arthritis due 
to secondary hyperuricemia is uncommon. When it 
does occur, the radiological appearances are identi- 
cal to those of primary gout, but may involve un- 
usual joints. 
Oxalic acid is an end product of the metabolism of 
ascorbic acid and a number of aminoacids. Its accu- 
mulation in chronic renal failure managed by dialy- 
sis is probably the commonest cause of secondary 
oxalosis and can be aggravated by inappropriate and 
excessive vitamin C supplementation (24, 25). Cal- 
cium oxalate crystals are deposited in the kidneys, 
heart, blood vessels, bone, synovium, articular carti- 
lage and synovial fluid. Articular presentations in- 
clude joint effusions, an acute symmetrical small 
joint arthritis and cutaneous calcinosis that may be 
mistaken for gouty tophi (25, 26). Radiographic man- 
ifestations are infrequent but distinctive (Figure 1) 
(25, 26). These principally involve the hands and 
feet. Miliary, moderately radioopaque densities, 
composed of calcium oxalate, occur predominantly 
in the soft tissue of the digits, particularly around the 
pulps, in the synovium, periarticular structures and 
tendon sheaths, with a tendency to involve the flexor 
surfaces. Faint chondrocalcinosis and occasionally 
intraosseous calcifications may also be seen. Subarti- 
cular erosions, intraosseous cysts and digital acroos- 
teolysis have been described but require careful dif- 
ferentiation from the effects of secondary 
hyperparathyroidism. 
Hyperparathyroidism 
All of the articular manifestations described in pri- 
mary hyperparathyroidism are seen in patients with 
renal osteodystrophy, although chondrocalcinosis is 
relatively unusual in secondary hyperparathyroid- 
ism. Articular lesions result from bone resorption, 
crystal deposition, and tendon or ligamentous laxity 
or rupture. Brown tumors develop from localized ar- 
eas of trabecular resorption with accumulation of fi- 
brous tissue and giant cells. With adequate hemo- 
dialysis, the changes due to secondary 
hyperparathyroidism rarely progress and usually de- 
crease in severity. 
Subperiosteal resorption of bone, typically in- 
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FIGURE 1. Secondary oxalosis in chronic renal failure. 
(A) A distinctive pattern of cutaneous, periarticular, and 
tendon-sheath calcification is shown. Acroosteolysis of 
the index and little fingers, together with subchondral ero- 
sions of the first carpometacarpal joint, are also observed. 
(B) Linear and milary calcification is shown in the soft 
tissues beneath the calcaneum in the same patent. 
volving the radial aspect of the shaft of the phalan- 
ges, is a well-recognized feature of hyperparathy- 
roidism. The marginal areas of joints may be 
involved, often in continuity with the shaft of the 
bone, resulting in periarticular erosions [Figure 2). 
These may be particularly prominent in the hands, 
wrists, and feet, and can mimic the appearances of 
an inflammatory arthritis (27, 28). The erosions may 
have well-marked or poorly defined, irregular out- 
lines, and occur most frequently in the distal inter- 
phalangeal joints. When the metacarpophalangeal 
joints are involved, a predilection for the ulna aspect 
of the metacarpal head has been noted, contrasting 
with the radial predominance of rheumatoid arthri- 
tis (27). With control of the hyperparathyroidism the 
erosions become punched out, well-defined corti- 
cated areas of bone destruction. The joint spaces 
usually remain preserved. 
Subchondral bone resorption occurs in the axial 
as well as the appendicular skeleton. It results in loss 
of definition of the subchondral bone and collapse of 
the articular surface. This may be accompanied by 
poorly defined intraosseous radiolucencies and sub- 
chondral sclerosis. The findings in the sacroiliac 
joints are most distinctive, where symmetrical, ill- 
defined erosions with sclerotic articular margins pre- 
dominantly involve the iliac sides of the joints. In 
the early stages the findings can be similar to those of 
ankylosing spondylitis (29). Subchondral bone re- 
sorption at the discovertebral junctions results in 
multiple Schmorl’s nodes, and may cause irregular 
destruction of the vertebral end plates. The thoracic 
spine is usually involved (29). 
Although secondary hyperparathyroidism and 
crystal deposition may contribute to the osseous and 
articular findings observed in chronic renal failure 
and its treatment (30, 31, 32), it is becoming increas- 
ingly apparent that some of the abnormalities previ- 
ously attributed to these conditions are in fact due to 
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FIGURE 2. Secondary hyperparathyroidism with mar- 
ginal erosions in the hand. Typical changes of secondary 
hyperparathyroidism due to chronic renal failure are evi- 
dent, including subperiosteal resorption and acroosteoly- 
sis. In addition, numerous marginal erosions are shown, 
most pronounced in the DIP joints and along the ulna 
aspects of the metacarpal heads (arrows). 
dialysis-related amyloidosis. This is discussed in the 
following section. 
Dialysis-Related Amyloidosis 
A painful dialysis-related arthropathy, unrelated to 
crystal deposition or renal osteodystrophy, has re- 
cently been shown to be due to the deposition of a 
unique form of amyloid derived from circulating 
beta 2-microglobulin (33, 34, 35). It is characterized 
by painful stiff joints, usually first involving the 
shoulder, and less commonly the hands, wrists, 
knees, and other large joints (36). Involvement tends 
to be bilateral and symmetrical, and is frequently 
associated with the carpal tunnel syndrome and 
tenosynovitis (36, 37). The condition is seldom seen 
before five years of treatment but occurs with in- 
creasing frequency the longer the duration of dialy- 
sis. After ten years, up to 80% of patients may be 
symptomatic (37). 
The amyloid protein is derived from circulating 
beta 2-microglobulin, a low-molecular-weight pro- 
tein that is normally freely filtered and metabolized 
by the kidney (38). It is not, however, readily dia- 
lysed by the commonly used Cuprophane mem- 
branes. In long-term-maintenance hemodialysis this 
results in elevated serum levels with progressive ac- 
cumulation and deposition in bony and soft-tissue 
structures. Even with the recently introduced higher 
permeability membranes that will dialyse beta Zmi- 
croglobulin, its rate of formation still exceeds the 
rate of removal (39). 
Although due to a distinctive biochemical form of 
amyloid, dialysis-related amyloidosis demonstrates 
many similar clinical and radiological findings to 
those seen in immunoglobulin associated amyloido- 
sis (40, 41). As in immunoglobulin-related amyloi- 
dosis, the amyloid protein accumulates in all com- 
ponents of the joint and its surrounding tissues, with 
the radiological findings reflecting this intraarticu- 
lar- and periarticular distribution. The findings are 
usually bilateral and symmetrical, with well-defined 
subarticular radiolucent lesions, typically in the 
wrists, hips, and shoulders, occurring in association 
with soft-tissue masses (Figure 3) (34, 42, 43). In the 
large joints the appearances can mimic those of pig- 
mented villonodular synovitis. Articular and in- 
traosseous deposits may be asymptomatic (34). 
In the wrist the radial aspect is most often in- 
volved, typically with 2-3 mm diameter radiolucen- 
ties initially being seen in the lunate, capitate, and 
scaphoid bones (Figure 3A) (42,44). In the shoulder 
the lesions are usually found around the anatomical 
neck of the humerus. In the hip, the acetabular radio- 
lucencies are immediately subarticular and often di- 
rectly superior to the joint space. They characteristi- 
cally develop in the subcapital region of the femur 
along the superolateral aspect of the neck where they 
are associated with a high incidence of pathological 
fracture (Figure 3B) (34, 42). 
These focal radiolucent lesions slowly progress in 
size and typically develop fine sclerotic margins 2 to 
4 years after they first appear (42). In the early stages, 
the surrounding trabeculae may show increased den- 
sity, especially around the acetabular lesions. The 
radiolucent lesions occasionally appear multilocula- 
ted or coarse as they increase in size. Internal miner- 
alization, bony expansion, and periosteal reactions 
do not occur. The joint space is preserved until late 
in the disease. 
These lesions are probably the result of a combi- 
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nation of pressure scalloping from synovial masses 
and intraosseous subchondral deposits. Occasion- 
ally they remain static in size over a number of years, 
but they do not regress and show no relationship to 
other signs of renal osteodystrophy. These features 
help to distinguish them from brown tumors of hy- 
perparathyroidism. 
Occasionally, predominantly in the distal inter- 
phalangeal joints and unrelated to hyperparathy- 
roidism or crystal deposition, severe subchondral 
erosions with marked osseous destruction are dem- 
onstrated resembling the appearances of erosive os- 
teoarthritis (Figure 4) (31, 32). Corner erosions of 
vertebral bodies resulting in Schmorl’s nodes may 
also occur (45). The cause of these abnormalities and 
their possible relationship to amyloidosis have not 
been determined. 
Newer imaging techniques are useful for showing 
the extent, distribution, and location of involvement 
and to characterize the abnormalities. Computerized 
tomography of biopsy-proven amyloid lesions in the 
shoulder, femoral head, acetabulum, patella, and ta- 
lus and has demonstrated well-defined, often multi- 
locular, periarticular cystic lesions with internal at- 
tenuation values between 0 and 30 H.U. (42, 44). A 
soft-tissue component is not always identified (46). 
Magnetic resonance (MR) imaging may demon- 
strate particularly well the extent and distribution of 
FIGURE 3. Dialysis related amyloidosis. (A) Wrist: Nu- 
merous radiolucent lesions are present in the scaphoid, 
lunate, capitate and hamate. The lunate has partially col- 
lapsed with widening of the scapholunate intraosseous 
distance. Erosions of the carpal bones, the proximal inter- 
metacarpal joints, the distal radioulnar joint and the ulna 
notch are demonstrated (arrow). The joint spaces are pre- 
served or slightly widened. (B) Left hip: A pathological 
fracture (white arrow) is shown through a large radiolu- 
cent lesion (black arrows) involving the superolateral as- 
nect of the femoral neck. Further erosions are mesent in 
ihe subcapital region of the femur (open orrow’s) and 
medial wall of the acetabulum. 
osseous, articular, and soft-tissue involvement by 
amyloid [Figure 5). Lesions that are apparently in- 
traosseous on conventional radiographs may be 
shown to be contiguous with well-defined articular 
surface erosions on MR imaging. The amyloid depo- 
sition has an intermediate-to-low signal intensity on 
all sequences. Synovial involvement may be associ- 
ated with a significant joint effusion. The MR signal 
characteristics of amyloid infiltration, intermediate 
between fibrocartilage and muscle on all sequences, 
distinguish it from cellular or high water containing 
lesions, such as inflammatory masses, acute or 
chronic synovitis, and brown tumors of hyperpara- 
thyroidism. 
the 
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FIGURE 4. Unusual arthropathy in a 36-year-old man on 
long-term hemodialysis. Extensive subchondral erosions 
are shown involving the DIP joints of the index, middle, 
and ring fingers, the little finger PIP joint, and the first 
carpometacarpal joint. The appearance and distribution of 
the findings resemble erosive osteoarthritis. However, 
joint space narrowing and numerous marginal erosions are 
demonstrated in the carpal bones, the PIP joints and the 
MCP joints, particularly along the ulna aspect of the meta- 
carpal heads (arrows]. Similar findings were present in the 
right hand. There was no current evidence of secondary 
hyperparathyroidism. The cause of this occasionally ob- 
served arthropathy in long-term hemodialysis is uncer- 
tain 
Conventional radionuclide bone scanning is unre- 
liable for identifying amyloid deposits, with some 
lesions showing increased radiotracer uptake while 
others demonstrate no abnormal uptake (47). Scinti- 
graphic scanning with iodine-123 labeled serum 
amyloid P component has been assessed in systemic 
(nondialysis related) amyloidosis (48). The radioiso- 
tope appears to localize rapidly and specifically in 
amyloid deposits. As amyloid P component is com- 
mon to all forms of amyloid (33), this isotope may 
prove to be a valuable noninvasive method of screen- 
ing for dialysis-related amyloidosis, assessing the ex- 
tent of involvement and monitoring its progress. 
A rapidly progressive destructive spondyloarthro- 
pathy that simulates an infectious discitis has also 
been described in patients on long-term hemodialy- 
sis (Figure 6) (21, 22, 23, 45, 49, 50). Although this 
may involve any intervertebral level, the cervical 
spine is a particularly common site to be affected, 
contrasting with the intervertebral changes of hyper- 
parathyroidism, which has a predilection for the tho- 
racic spine. The presenting symptoms are of local- 
ized pain with radiographic changes occurring 
rapidly over a period of weeks to months. The char- 
FIGURE 5. Magnetic resonance imaging in dialysis-re- 
lated amyloidosis. Anterior (A & B) and posterior (B & C) 
coronal images of the knee. (A & C) GE 1.5T; SE 2000/25. 
(B & D) SE 2000/80. Numerous low signal intensity soft- 
tissue deposits, some arranged in a whorl-like pattern, are 
shown in the synovium (white arrows) and around the 
tibia1 origin of the posterior cruciate ligament (black ar- 
row). The deposits have a low signal intensity on the first 
and second echo images, contrasting with the high signal 
intensity of the surrounding joint effusion on the second 
echo images. Tibia1 plateau erosions also contain material 
with a low signal intensity on both echoes (black arrow & 
open arrow). (E) Axial view (SE 600125). The extent of the 
tibia1 plateau erosions (arrows) and surrounding abnormal 
soft tissues are well demonstrated. 
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FIGURE 5 continued. 
acteristic features include progressive disc space 
narrowing, marked ill-defined and extensive end- 
plated erosions, and modest subchondral sclerosis, 
usually confined to one or two levels. A helpful dif- 
ferentiating feature from infection is the absence of 
an adjacent soft-tissue mass or swelling. Similar 
findings may also be seen in the facet joints (22, 23). 
Early studies in which calcium pyrophosphate 
and hydroxyapatite crystals were found in these le- 
sions suggested this may be a crystal induced ar- 
thropathy (21,49). More recently, beta &microglobu- 
lin-derived amyloid has been documented in the 
lesions, sometimes in association with characteristic 
amyloid changes in other joints (22, 23). It would 
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FIGURE 6. Cervical spine: Erosive spondyloarthropathy 
in long-term hemodialysis. Intervertebral disc space nar- 
rowing is shown at C5-C6 (open arrow) with erosion of the 
adjacent end plates, modest localised kyphosis, and slight 
forward slip of C5 on C6. The upper end-plated of C4 is 
also irregular. 
appear therefore, that this is a further manifestation 
of dialysis-related amyloidosis and that the crystal 
deposition is most likely secondary to bone fragmen- 
tation and destruction rather than its cause. 
MR imaging is valuable in distinguishing this de- 
structive spondyloarthropathy from infectious spon- 
dylitis by demonstrating a low to intermediate signal 
intensity abnormality at the discovertebral junction 
on all sequences and the absence of a paraspinal or 
prevertebral mass (50). These changes contrast with 
infectious discitis where there is low signal intensity 
on Tl-weighted images and irregular increased sig- 
nal intensity from the disc and adjacent end plates 
on the T&weighted images. 
It is apparent that numerous and complex factors, 
not all of which are understood, contribute to the 
osseous and articular manifestations of patients with 
renal failure. Various complications arising from its 
treatment compound the difficulty of identifying a 
specific mechanism for many of the articular 
changes. Although amyloid deposition has recently 
been recognized as an important cause of osteoarti- 
cular damage in those on maintenance hemodialysis, 
it is likely that other factors and complex interac- 
tions will be identified as disease modifiers or signifi- 
cant pathogens in these patients. 
CRYSTAL-DEPOSITION DISEASES 
Gouty Arthritis 
The pathogenesis and manifestations of gouty arthri- 
tis are the most well-defined and least controversial 
of the crystal-deposition diseases. Idiopathic gout 
accounts for the majority of cases, most frequently 
affecting men. It is conveniently divided into four 
stages: i) asymptomatic hyperuricemia, ii) acute 
gouty arthritis, iii) intercritical gout-an asympto- 
matic period between acute attacks that may last 
from months to years. Recovery between attacks is 
eventually incomplete and leads to iv) chronic 
tophaceous gout-occurs, usually after an interval of 
many years, in less than half of those who suffer 
from intermittent, episodic acute gouty attacks. It is 
typically an asymmetric polyarthritis with a ten- 
dency to involve the lower limbs. 
Chronic tophaceous gout has a predilection for 
damaged synovial joints of the extremities, particu- 
larly the hands and feet, often occuring at the site of 
pre-existing osteoarthritis (51). Axial involvement is 
uncommon, but occurs occasionally in the acromio- 
clavicular and sacroiliac joints. Chondrocalcinosis 
of fibrocartilage is sometimes associated. For unex- 
plained reasons, the coexistence of gout and rheuma- 
toid arthritis is very rare and similarly, superim- 
posed septic arthritis of an involved joint is 
uncommon. 
The radiological manifestations of chronic topha- 
ceous gout reflect the pathological deposition of 
urate in all components of the joint and periarticular 
tissues. Eccentric soft-tissue nodules of modest in- 
creased amorphous density, which occasionally cal- 
cify, show an affinity for the dorsal and extensor 
surfaces of the hands, feet, ankles, elbows, and knees 
(Figure 7). The olecranon bursa is a frequent site. 
Bony and adjacent soft-tissue deposits result in ec- 
centric subchondral, marginal and juxtaarticular ero- 
sions, usually with well-defined, “punched out” 
margins. Periosteal bone apposition is relatively un- 
common, but may be seen adjacent to an obvious 
tophus with contiguous bone destruction. Bone min- 
eralization is typically normal except in acute at- 
tacks, and the joint space is initially preserved. Sub- 
sequently, concentric joint space narrowing is 
observed (52, 53, 54). 
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FIGURE 7. Gouty olecranon bursitis with erosion of the 
adjacent olecranon process. Characteristic amorphous ar- 
eas of increased density are shown in the soft tissues be- 
hind the olecranon process. The underlying osseous ero- 
sion has overhanging margins [arrow): an uncommon 
finding outside of the hands and feet. A large effusion is 
present. 
Bony ankylosis is very uncommon, but is occa- 
sionally observed in the carpus with extensive dis- 
ease, and exceptionally in an interphalangeal joint. 
Intraosseous lesions occur near a joint, and are often 
multioculated with scalloped margins. Occasionally 
a solitary round area of bone destruction is seen. In 
the hands, wrists, and feet intraosseous lesions occa- 
sionally calcify (Figure 8) and may resemble enchon- 
dromas or bone infarcts (55). This is usually associ- 
ated with extensive articular destruction and 
coexistent areas of soft-tissue calcification, fre- 
quently in the presence of renal impairment. 
Osteoarthritis of the first metatarsophalangeal 
joint predisposes to this characteristic site of gouty 
tophaceous involvement (56). Erosions typically oc- 
cur on the dorsal and medial aspect of the metatarsal 
head [Figure 9). The characteristic erosion with an 
overhanging elevated margin is seen principally in 
the hands and feet, and occurs in approximately 40% 
of those with erosions (54). Occasionally it may be 
observed at other articular sites (Figure 7). 
Calcium Pyrophosphate Deposition 
Articular deposition of calcium pyrophosphate 
(CPPD) is a common age-related phenomenon. It is 
frequently asymptomatic and unassociated with 
structural joint damage (57, 58). Occasionally, acute 
attacks of synovitis occur resulting in pseudogout 
(59). Attacks are often provoked by intercurrent ill- 
ness, local trauma, or surgery and most commonly 
involve the knee, and less often the wrist, hip, shoul- 
der, and elbow. Osteoarthritis and CPPD frequently 
coexist, but in some patients, a distinctive modified 
pattern of osteoarthritis is seen-“pyrophosphate ar- 
thropathy” (58,60,61). Characteristic features of this 
arthropathy, distinguishing it from conventional os- 
teoarthritis, include an unusual articular and intraar- 
titular distribution, large and numerous subchon- 
dral cysts, and often prominent osteophyte 
formation. The subchondral cysts have sclerotic in- 
distinct edges and characteristically occur in clus- 
ters or as multiple small contiguous lucencies along 
the subchondral bone (Figure 10). Their presence 
may precede articular cartilage loss. Numerous in- 
traarticular osteochondral fragments are frequently 
present. When profuse, these can occasionally be 
confused with synovial chondromatosis (62). Un- 
commonly, severe destructive changes may mimic 
ischemic necrosis or neuropathic joint disease. 
Pyrophosphate arthropathy may occur secondary 
to a number of other metabolic conditions, including 
primary and secondary hemochromatosis (63). Fa- 
milial forms of articular chondrocalcinosis have also 
FIGURE 8. Intraosseous tophaceous calcification in gout. 
Prominent soft-tissue swelling with gouty erosions and 
osteophyte formation of both great toe metatarsophalan- 
geal joints. In the right proximal phalanx, punctate and 
curvilinear calcification (black arrow) of an intraosseous 
tophaceous deposit is associated with extensive extraarti- 
cular bony destruction and an overhanging margin (white 
arrow). 
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been described, often unassociated with articular 
symptoms or structural joint damage (64, 65). 
The distinctive structural changes of pyrophos- 
phate arthropathy occasionally precede radiologi- 
cally identifiable cartilage calcification and should 
be considered whenever an unusual combination of 
articular changes are seen in osteoarthritis, such as 
D D 
FIGURE 9. Bilateral great toe metatarsophalangeal (MTP) 
joint involvement in gout. (A) Anteroposterior view. (B) 
Medial oblique projection. Soft-tissue swelling is shown 
adjacent to the medial aspects of both MTP joints. Erosions 
are most evident on the oblique projection due to their 
dorsomedial location [arrows). The right MTP joint is a 
little narrowed. 
the radiocarpal and metacarpophalangeal joint in- 
volvement (58, 60). Wrist involvement may be asso- 
ciated with carpal instability secondary to ligamen- 
tous laxity and disruption of the interosseous 
ligaments, especially between the scaphoid and lu- 
nate (66). 
CPPD has a predilection for the fibrocartilagenous 
menisci of the knee, the triangular cartilage of the 
arthropathy of the right 
shoulder. Marked -joint space narrowing, subchondral 
sclerosis, and prominent inferior osteophyte formation are 
shown, together with a number of intraarticular osteo- 
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wrist, the public symphysis and the labra of the ace- 
tabulum and glenoid. It is more common than hya- 
line cartilage calcification, which occurs especially 
in the knee, wrist, hip, and elbow. 
Hyaline cartilage calcification is not generally 
seen in the absence of fibrocartilage involvement 
(61). Surprisingly, in view of the fibrocartilagenous 
composition of the temporomandibular joint, in- 
volvement of this site is infrequent, although possi- 
bly underrecognized (67). 
The characteristic appearance of fibrocartilage 
deposition is a coarse granular calification, whereas 
hyaline cartilage deposition has a more delicate lin- 
ear appearance. A spectrum of changes are seen with 
minimal involvement affecting only the knee me- 
nisci, while in more severe deposition the synovium, 
capsule, ligaments, and bursae are involved. When 
tendons are affected, often long segments are in- 
volved (61). Crystal deposits in the menisci of the 
knee have also been observed to be transient on se- 
rial radiographs (68). 
Massive tumoral deposition of calcium pyrophos- 
phate in periarticular locations is a rare manifesta- 
tion. These deposits may initially be mistaken for a 
malignant chondroid or other soft-tissue tumors and 
may be unassociated with other manifestations of 
CPPD disease; sites that have been cited include the 
temporomandibular joint (69, 70), wrist, and hands 
(71, 72, 73). 
Calcium Hydroxyapatite Deposition 
Hydroxyapatite deposition is a well-recognized 
cause of various periarthritic inflammatory condi- 
tions (74). Macroscopic aggregates may be confirmed 
radiographically by the presence of localized areas of 
soft-tissue calcification. These deposits are com- 
monly seen about the shoulder and small joints of 
the hands, although they are not necessarily sympto- 
matic. Intraarticular deposition of hydroxyapatite 
crystals is less frequently observed but the accumu- 
lation of large quantities of crystals is associated 
with a striking form of destructive joint disease (Fig- 
ure 11). It has been suggested, but not conclusively 
shown, that this may be a specific subset of osteoar- 
thritis analogous to pyrophosphate arthropathy (i’s). 
The possibility of such an “apatite-associated-de- 
structive-arthritis” has received little attention in the 
radiological literature. 
Patients affected by this uncommon condition are 
usually elderly women who present with rapidly 
progressive joint damage, large, often blood-stained 
effusions, and joint instability. Shoulder joint in- 
volvement predominates, but lateral compartment 
FIGURE 11. Apatite-associated arthropathy. Marked sub- 
chondral bony attrition of the humerus, glenoid, acro- 
mium, and outer portion of the clavicle is shown with 
little subchondral sclerosis and no osteophyte formation. 
A number of bony fragments are evident (white arrow). 
Disruption of the rotator cuff has resulted in upward sub- 
luxation of the humeral head. A smooth pressure defect 
along the medical aspect of the proximal humerus is 
present (black arrows). Numerous hydroxyapatite parti- 
cles were aspirated from the shoulder of this elderly 
women with a large joint effusion. (Courtesy of I. Watt, 
M.D., Bristol, UK). 
knee disease is common and the hip may also be 
affected (76, 77, 78, 79). Involvement of the midtar- 
sal joints have also been described (77). 
Radiographs demonstrate marked subchondral 
bony attrition, with relatively modest subchondral 
sclerosis in the absence, or presence of only mini- 
mal, osteophyte formation and large-joint effusions. 
Periarticular calcification is frequently present. Scal- 
loping pressure defects of adjacent osseous struc- 
tures occur from the large effusions. Periarticular os- 
teoporosis is usually minimal or absent. Marginal 
erosions do not occur. Chondrocalcinosis may be 
present at remote joints. The appearances may 
mimic an atrophic form of neuropathic joint destruc- 
tion, or overlap with some features of other diseases, 
such as rheumatoid arthritis or calcium pyrophos- 
phate deposition disease (76, 77, 78). 
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\ It has been suggested that a number of named syn- 
dromes applied to this destructive arthropathy, such 
as Milwaukee shoulder (76), analgesic hip (78, 80), 
and rapidly progressive, or atrophic osteoarthritis, 
may represent a common articular response at differ- 
ent joint sites to a process possibly activated by apa- 
tite crystals (78). As with pyrophosphate arthropa- 
thy, it is important to avoid the implication that the 
crystals are necessarily the cause of the structural 
changes (77). In vitro and synovial fluid studies have 
shown that apatite crystals can induce activation of 
collagenase and other enzymatic pathways that may 
accelerate joint damage (76). The identification of 
hydroxyapatite crystals, however, requires special 
staining techniques with Alizarin red (81) or analyti- 
cal electron microscopy (82). For this reason hy- 
droxyapatite crystals and other basic calcium phos- 
phates are easily overlooked in the routine analysis 
of synovium and synovial fluid. Many of the cases of 
a destructive arthropathy attributed to pyrophos- 
phate disease originally described by Menkes and 
other authors, show the typical clinical and radiolog- 
ical features of apatite associated destructive ar- 
thropathy (83). 
The complex interactions involved in the spec- 
trum of disease manifestations exhibited in the crys- 
tal arthropathies, ranging from asymptomatic depo- 
sition, to acute synovitis and chronic structural joint 
damage are not completely understood. Pure crystal 
deposits are not always present. An association ex- 
ists between gout and calcium pyrophosphate depo- 
sition, and between calcium pyrophosphate and hy- 
droxyapatite deposition (61,811. Mixtures of various 
basic calcium phosphates also occur (84). Whether 
the crystal deposition initiates the joint damage is 
questionable. It is possible that joint damage predis- 
poses to crystal deposition, which in turn may mod- 
ify the underlying disease process (85). Occasionally 
this results in a distinctive pattern of radiographic 
changes. The recognition of these are important in 
suggesting the diagnosis of a crystal-associated ar- 
thropathy and in identifying subsets of osteoarthritis 
that may have prognostic and therapeutic implica- 
tions. 
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